Tracie Leonhardt
Endocrinology, Diabetes & Metabolism · Largo, FLNPI 1588601751
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 109 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by Takeda Pharmaceuticals U.S.A., Inc. at 26.3% of the total. Reporting peaked in 2023 at $501 and has fallen 89.6% since, to $52 in 2025. That places this record below the midpoint for endocrinology, diabetes & metabolism clinicians in FL, where the typical reported total is $3,445.
Across 109 payments — averaging $17.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$514
- AstraZeneca$393
- Lilly USA, LLC$128
- Romark Laboratories, LC$124
- Alnylam Pharmaceuticals Inc.$105
- GSK$103
- plus $588 from 13 others
What the payments were for
- Food & beverage$1,955100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $514 |
| AstraZeneca | 27 | $393 |
| Lilly USA, LLC | 8 | $128 |
| Romark Laboratories, LC | 9 | $124 |
| Alnylam Pharmaceuticals Inc. | 5 | $105 |
| GSK | 1 | $103 |
| Amgen | 2 | $96 |
| Novo Nordisk | 5 | $80 |
| Corcept Therapeutics | 4 | $63 |
| Azurity Pharmaceuticals, Inc. | 3 | $62 |
| Dexcom, Inc. | 3 | $60 |
| Ultragenyx Pharmaceutical Inc. | 3 | $58 |
| Amarin Pharma, Inc. | 2 | $36 |
| Shire North American Group Inc | 2 | $33 |
| Acella Pharmaceuticals, LLC | 2 | $32 |
| CSL Behring | 1 | $23 |
| Abbott | 1 | $19 |
| C2n Diagnostics, LLC | 1 | $14 |
| AbbVie | 1 | $12 |
How this compares
$1,955 in reported general payments places this provider in the 40th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.
See all endocrinology, diabetes & metabolism providers in Florida →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 33 | $45,445 |
| FarxigaDapagliflozin Propanediol | 16 | $13,901 |
| ProgesteroneProgesterone, Micronized | 98 | $6,158 |
| Np ThyroidThyroid,pork | 67 | $5,507 |
| Liothyronine Sodium | 69 | $3,010 |
| ValacyclovirValacyclovir Hcl | 28 | $1,770 |
| Testosterone Cypionate | 16 | $751 |
| Hydroxychloroquine Sulfate | 20 | $710 |
| Doxycycline Hyclate | 13 | $501 |
| Spironolactone | 27 | $369 |
| Metformin Hcl ErMetformin Hcl | 25 | $326 |
| Levothyroxine Sodium | 36 | $289 |
| Trazodone Hcl | 14 | $242 |
| Amlodipine Besylate | 21 | $150 |
| Anastrozole | 25 | $131 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $128 | $45,44533 claims |
| AstraZenecaFarxiga | $393 | $13,90116 claims |
| Acella Pharmaceuticals, LLCNp Thyroid | $32 | $5,50767 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 586 endocrinology, diabetes & metabolism providers in Florida.
Other endocrinology, diabetes & metabolism in Largo
- Brian LakeLargo$888K
- Jay SkylerMiami$2.2M
- Arelis MaderaPort Charlotte$1.7M
- Damon TantonOrlando$1.2M
- Gaston PonteMelbourne$906K
- David SuttonJacksonville$783K
- Mae Sheikh AliJacksonville$751K
- Richard PratleyOrlando$735K
- Lee MetchickDeland$728K
- Misha DenhamCoral Gables$673K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.